HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Once-daily administration of ceftriaxone in the treatment of meningitis and other serious infections in children.

Abstract
Forty-three children (ten neonates, 15 infants and 18 older children) were treated with single daily doses of ceftriaxone (50 to 100 mg/kg) intravenously or intramuscularly for serious bacterial infections. The infections included meningitis (31 patients), brain abscesses (four patients), septicaemia (three patients), pleuro-pneumonia (two patients), septic arthritis and soft tissue phlegmona (three patients). No other antibacterial agents were used except in four patients with brain abscesses, in whom ceftriaxone was combined with ornidazole. The overall bacteriological cure rate was 98%, and sterilisation of the cerebrospinal fluid occurred in 27 of 28 patients (96%) with proven bacterial meningitis. Two patients died, three survived with severe neurological sequelae; one neonate required partial gut resection. A complete clinical cure was achieved in the remaining 37 patients. Only one treatment failure was directly related to the drug therapy. The only side effect noted were sterilisation of the gut with overgrowth of Candida albicans in 35% of neonates and infants, an prolonged fever in 13% of all patients. Ceftriaxone given in a 24-hourly regimen is convenient and highly effective in serious bacterial infections in children and is without significant toxicity.
AuthorsE Martin
JournalEuropean journal of clinical microbiology (Eur J Clin Microbiol) Vol. 2 Issue 5 Pg. 509-15 (Oct 1983) ISSN: 0722-2211 [Print] Germany
PMID6315428 (Publication Type: Journal Article)
Chemical References
  • Ceftriaxone
  • Cefotaxime
Topics
  • Adolescent
  • Arthritis, Infectious (drug therapy)
  • Bacterial Infections (drug therapy)
  • Brain Abscess (drug therapy)
  • Cefotaxime (administration & dosage, analogs & derivatives, cerebrospinal fluid, therapeutic use)
  • Ceftriaxone
  • Cellulitis (drug therapy)
  • Child
  • Child, Preschool
  • Drug Evaluation
  • Humans
  • Infant
  • Infant, Newborn
  • Meningitis (drug therapy)
  • Pleuropneumonia (drug therapy)
  • Sepsis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: